Orient Technologies (NSE: ORIENTTECH) Q3 FY26 results: Why short-term margin pain may be the price of securing long-cycle government and services revenue
Read More 5 minute read Pharma Industry News BillionToOne’s Unity Fetal Risk screen reshapes cystic fibrosis prenatal testing with early therapeutic pathways BillionToOne’s Unity Fetal Risk Screen delivers 100% sensitivity in cystic fibrosis prenatal detection, unlocking earlier treatment options for families. bySoujanya RaviSeptember 23, 2025